Novel Strategies for Enhanced Removal of Persistent Bacillus anthracis Surrogates and Clostridium difficile Spores from Skin

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Nerandzic, Michelle M ^a   Rackaityte, Elze ^a   Jury, Lucy A ^a   Eckart, Kevin ^a   Donskey, Curtis J ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HYPOCHLOROUS ACID; SOAP; SODIUM CHLORIDE; TRICLOSAN; WATER;

ARTICLE; BACILLUS ANTHRACIS; BACILLUS ATROPHAEUS; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; BACTERIAL SPORE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; HAND WASHING; HUMAN; MALE; NONHUMAN; PATIENT SAFETY; SKIN CULTURE; SKIN DECONTAMINATION; SKIN IRRITATION;

BACILLUS ANTHRACIS; BATHS; CLOSTRIDIUM DIFFICILE; CROSS-OVER STUDIES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HAND; HAND DISINFECTION; HUMANS; HYGIENE; HYPOCHLOROUS ACID; MALE; OXIDANTS; SKIN; SOAPS; SOLUTIONS; SPORES, BACTERIAL; TREATMENT OUTCOME; WATER;

BACILLUS ANTHRACIS; CLOSTRIDIUM DIFFICILE;

EID: 84879750989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068706     Document Type: Article

References (35)

1. Setlow P, (2007) I will survive: DNA protection in bacterial spores. Trends Microbiol 15: 172-180. doi:10.1016/j.tim.2007.02.004. PubMed: 17336071.
2. Kelly CP, LaMont JT, (2008) Clostridium difficile: more difficult than ever. N Engl J Med 359: 1932-1940. doi:10.1056/NEJMra0707500. PubMed: 18971494.
3. Poxton IR, McCoubrey J, Blair G, (2001) The pathogenicity of Clostridium difficile. Clin Microbiol Infect 7: 421-427. doi:10.1046/j.1198-743x.2001.00287.x. PubMed: 11591205.
4. Sethi AK, Al-Nassir WN, Nerandzic MM, Donskey CJ, (2009) Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 30: 13-17. doi:10.1086/592710. PubMed: 19046063.
5. Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD, (2009) Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 30: 939-944. doi:10.1086/605322. PubMed: 19715426.
6. Muto CA, Blank MK, Marsh JW, Vergis EN, O'Leary MM, et al. (2007) Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 45: 1266-1273. doi:10.1086/522654. PubMed: 17968819.
7. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442-2449. doi:10.1056/NEJMoa051639. PubMed: 16322602.
8. Friedlander AM, (2000) Anthrax: clinical features, pathogenesis, and potential biological warfare threat. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. Vol 20. Malden, MA: Blackwell Publishing House Science. pp.: 335-349.
9. Swartz MN, (2001) Recognition and management of anthrax-an update. N Engl J Med 345: 1621-1626. doi:10.1056/NEJMra012892. PubMed: 11704686.
10. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, et al. (2002) Anthrax as a biological weapon: updated recommendations for management. JAMA 287: 2236-2252.
11. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, et al. (2002) Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 8: 1019-1028. doi:10.3201/eid0810.020353. PubMed: 12396909.
12. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, et al. (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278: 399-411. doi:10.1001/jama.1997.03550050061035. PubMed: 9244332.
13. Centers for Disease Control and Prevention (2000) Biological and chemical terrorism: strategic plan for preparedness and response: recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 49(RR-4):: 1-14. PubMed: 10803503.
14. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455. doi:10.1086/651706. PubMed: 20307191.
15. Gerding DN, Muto CA, Owens RC, (2008) Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46: S43-S49. doi:10.1086/521861. PubMed: 18177221.
16. Fawley WN, Underwood S, Freeman J, Baines SD, Saxton K, et al. (2007) Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 28: 920-925. doi:10.1086/519201. PubMed: 17620238.
17. Barbut F, Menuet D, Verachten M, Girou E, (2009) Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 30: 507-514. doi:10.1086/597232. PubMed: 19379098.
18. Jabbar U, Leischner J, Kasper D, Gerber R, Sambol SP, et al. (2010) Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol; 31: 565-570. doi:10.1086/652772. PubMed: 20429659.
19. Bettin K, Clabots C, Mathie P, Willard K, Gerding DN, (1994) Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 15(11):: 697-702. doi:10.1086/646840. PubMed: 7852725.
20. Boyce JM, Pittet D, (2002) Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 51(RR-16):: 1-45. PubMed: 12418624.
21. Weber DJ, Sickbert-Bennett E, Gergen MF, Rutala WA, (2003) Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. JAMA 289: 1274-1277. doi:10.1001/jama.289.10.1274. PubMed: 12633189.
22. Edmonds SL, Zapka C, Kasper D, Gerber R, McCormack R, et al. (2013) Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 34: 302-305. doi:10.1086/669521. PubMed: 23388366.
23. Jury LA, Guerrero DM, Burant CJ, Cadnum JL, Donskey CJ, (2011) Effectiveness of routine patient bathing to decrease the burden of spores on the skin of patients with Clostridium difficile infection. Infect Control Hosp Epidemiol 32: 181-184. doi:10.1086/657911. PubMed: 21460475.
24. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, et al. (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: The effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 106: 306-312.
25. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, et al. (2009) The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter study. Crit Care Med 37: 1858-1865. doi:10.1097/CCM.0b013e31819ffe6d. PubMed: 19384220.
26. Borer A, Gilad J, Porat N, Megrelesvilli R, Saidel-Odes L, et al. (2007) Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect 67: 149-155. doi:10.1016/j.jhin.2007.07.023. PubMed: 17900759.
27. Shetty N, Srinivasan S, Holton J, Ridgway GL, (1999) Evaluation of microbicidal activity of a new disinfectant: Sterilox 2500 against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicans and several Mycobacterium species. J Hosp Infect 41: 101-105. doi:10.1016/S0195-6701(99)90046-4. PubMed: 10063471.
28. Selkon JB, Babb JR, Morris R, (1999) Evaluation of the antimicrobial activity of a new super-oxidized water, Sterilox, for the disinfection of endoscopes. J Hosp Infect 41: 59-70. doi:10.1016/S0195-6701(99)90038-5. PubMed: 9949966.
29. Niezgoda JA, Sordi PJ, Hermans MH, (2010) Evaluation of Vashe Wound Therapy in the clinical management of patients with chronic wounds. Adv Skin Wound Care 23: 352-357. doi:10.1097/01.ASW.0000383198.35815.a2. PubMed: 20664326.
30. Nerandzic MM, Donskey CJ, (2009) Effective and reduced-cost modified selective medium for isolation of Clostridium difficile. J Clin Microbiol 47: 397-400. doi:10.1128/JCM.01591-08. PubMed: 19073869.
31. Sorg JA, Sonenshein AL, (2008) Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190: 2505-2512. doi:10.1128/JB.01765-07. PubMed: 18245298.
32. Greenberg DL, Busch JD, Keim P, Wagner DM, (2010) Identifying experimental surrogates for Bacillus anthracis spores: a review. Investig Genet 1: 4. doi:10.1186/2041-2223-1-4. PubMed: 21092338.
33. Majcher MR, Bernard KA, Sattar SA, (2008) Identification by quantitative carrier test of surrogate spore-forming bacteria to assess sporicidal chemicals for use against Bacillus anthracis. Appl Environ Microbiol 74: 676-681. doi:10.1128/AEM.01715-07. PubMed: 18083869.
34. American Society for Testing and Materials (2006) Standard Test Method for Evaluation of Health Care Professional Handwash Formulation (Method E 1174-06). West Conshohocken, PA, American Society for Testing and Materials.
35. Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK, Donskey CJ, (2008) Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 46: 447-450. doi:10.1086/525267. PubMed: 18181742.